Network Topological Indices from Chem-Bioinformatics to legal sciences and back

Current Bioinformatics

Volumn 6, Issue 1, 2011, Pages 53-70

  Duardo Sanchez, Aliuska ^a   Patlewicz, Grace ^b,c   González Díaz, Humberto ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b JOINT RESEARCH CENTRE   (Italy)

^c DUPONT COMPANY   (United States)

Author keywords

Authorization of chemicals; Bioinformatics legal issues; Complex networks; Crime causality network; Evaluation; Graph theory; OECD; QSAR software copyright; QSPR models; REACH new laws of registration; Social networks; Spain financial law network; Topological Indices

Indexed keywords

AUTHORIZATION; BIOACTIVITY; BIOINFORMATICS; COMPUTATION THEORY; COMPUTATIONAL CHEMISTRY; COMPUTATIONAL METHODS; ELECTRIC NETWORK ANALYSIS; ELECTRIC POWER TRANSMISSION; ELECTRIC POWER TRANSMISSION NETWORKS; GRAPH THEORY; PROTEINS;

AUTHORIZATION OF CHEMICAL; BIOINFORMATIC LEGAL ISSUE; CRIME CAUSALITY NETWORK; EVALUATION; LEGAL ISSUES; OECD; QSAR SOFTWARE COPYRIGHT; QSPR MODEL; REACH NEW LAW OF REGISTRATION; SOCIAL NETWORK; SOFTWARE COPYRIGHTS; SPAIN FINANCIAL LAW NETWORK; TOPOLOGICAL INDEX;

COMPLEX NETWORKS;

ARTICLE; BIOINFORMATICS; CHEMINFORMATICS; COMPUTER PROGRAM; DATA BASE; ENTROPY; ENVIRONMENTAL HEALTH; FORENSIC MEDICINE; HUMAN; LEGAL ASPECT; METABOLISM; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; QUANTITATIVE STRUCTURE ACTIVITY OR PROPERTY RELATIONSHIP; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RISK ASSESSMENT; SOCIAL NETWORK; TOPOLOGICAL INDEX; VALIDATION STUDY;

ANIMALIA;

EID: 79953845618     PISSN: 15748936     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489311795222347     Document Type: Article

References (124)

1. Kennedy, D. Bioinformatics Law Resources. http://www.denniskennedy. com/index.aspx (11/9/2007).
2. Richon, A. A short history of bioinformatics. http://www.netsci.-org/Science/Bioinform/feature06.html (20/10/2007).
3. Una Ciencia Mixta. La unión hace la Bioinformática. Bioplanet may/jun, 2001.
4. Caballero J, Fernandez M. Artificial neural networks from MATLAB in medicinal chemistry. Bayesian-regularized genetic neural networks (BRGNN): application to the prediction of the antagonistic activity against human platelet thrombin receptor (PAR-1). Curr Top Med Chem 2008; 8: 1580-605.
5. Duardo-Sanchez A, Patlewicz G, Lopez-Diaz A. Current topics on software use in medicinal chemistry: intellectual property, taxes, and regulatory issues. Curr Top Med Chem 2008; 8: 1666-75.
6. Gonzalez MP, Teran C, Saiz-Urra L, Teijeira M. Variable selection methods in QSAR: an overview. Curr Top Med Chem 2008; 8: 1606-27.
7. Gonzalez-Diaz H. Quantitative studies on Structure-Activity and Structure-Property Relationships (QSAR/QSPR). Curr Top Med Chem 2008; 8: 1554.
8. Gonzalez-Diaz H, Prado-Prado F, Ubeira FM. Predicting antimicrobial drugs and targets with the MARCH-INSIDE approach. Curr Top Med Chem 2008; 8: 1676-90.
9. Helguera AM, Combes RD, Gonzalez MP, Cordeiro MN. Applications of 2D descriptors in drug design: a DRAGON tale. Curr Top Med Chem 2008; 8: 1628-55.
10. Ivanciuc O. Weka machine learning for predicting the phospholipidosis inducing potential. Curr Top Med Chem 2008; 8: 1691-709.
11. Vilar S, Cozza G, Moro S. Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery. Curr Top Med Chem 2008; 8: 1555-72.
12. Wang JF, Wei DQ, Chou KC. Drug candidates from traditional chinese medicines. Curr Top Med Chem 2008; 8: 1656-65.
13. Wang JF, Wei DQ, Chou KC. Pharmacogenomics and personalized use of drugs. Curr Top Med Chem 2008; 8: 1573-9.
14. Torrens F, Castellano G. Topological charge-transfer indices: From small molecules to proteins. Curr Proteomics 2009: 204-13.
15. Concu R, Dea-Ayuela MA, Perez-Montoto LG, et al. 3D entropy and moments prediction of enzyme classes and experimentaltheoretic study of peptide fingerprints in Leishmania parasites. Biochimi Biophys Acta 2009; 1794: 1784-94.
16. Ivanciuc O. Machine learning Quantitative Structure-Activity Relationships (QSAR) for peptides binding to Human Amphiphysin-1 SH3 domain. Curr Proteomics 2009; 4: 289-302.
17. Vilar S, Gonzalez-Diaz H, Santana L, Uriarte E. A network-QSAR model for prediction of genetic-component biomarkers in human colorectal cancer. J Theor Biol 2009; 261: 449-58.
18. Giuliani A, Di Paola L, Setola R. Proteins as Networks: A mesoscopic approach using haemoglobin molecule as case study. Curr Proteomics 2009; 6: 235-45.
19. Chou KC. Pseudo amino acid composition and its applications in bioinformatics, proteomics and system biology. Curr Proteomics 2009; 6: 262-74.
20. Chen J, Shen B. Computational analysis of amino acid mutation: A proteome wide perspective. Curr Proteomics 2009; 6: 228-34.
21. Zhong WZ, Zhan J, Kang P, Yamazaki S. Gender specific drug metabolism of PF-02341066 in rats--role of sulfoconjugation. Curr Drug Metab 2010; 11: 296-306.
22. Wang JF, Chou KC. Molecular modeling of cytochrome P450 and drug metabolism. Curr Drug Metab 2010; 11: 342-6.
23. Mrabet Y, Semmar N. Mathematical methods to analysis of topology, functional variability and evolution of metabolic systems based on different decomposition concepts. Curr Drug Metab 2010; 11: 315-41.
24. Martinez-Romero M, Vazquez-Naya JM, Rabunal JR, et al. Artificial intelligence techniques for colorectal cancer drug metabolism: ontology and complex network. Curr Drug Metab 2010; 11: 347-68.
25. Khan MT. Predictions of the ADMET properties of candidate drug molecules utilizing different QSAR/QSPR modelling approaches. Curr Drug Metab 2010; 11: 285-95.
26. Gonzalez-Diaz H, Duardo-Sanchez A, Ubeira FM, et al. Review of MARCH-INSIDE & complex networks prediction of drugs: ADMET, anti-parasite activity, metabolizing enzymes and cardiotoxicity proteome biomarkers. Curr Drug Metab 2010; 11: 379-406.
27. Gonzalez-Diaz H. Network topological indices, drug metabolism, and distribution. Curr Drug Metab 2010; 11: 283-4.
28. Garcia I, Diop YF, Gomez G. QSAR & complex network study of the HMGR inhibitors structural diversity. Curr Drug Metab 2010; 11: 307-14.
29. Chou KC. Graphic rule for drug metabolism systems. Curr Drug Metab 2010; 11: 369-78.
30. Concu R, Podda G, Ubeira FM, Gonzalez-Diaz H. Review of QSAR models for enzyme classes of drug targets: Theoretical background and applications in parasites, hosts, and other organisms. Curr Pharm Design 2010; 16: 2710-23.
31. Estrada E, Molina E, Nodarse D, Uriarte E. Structural contributions of substrates to their binding to P-Glycoprotein. A TOPS-MODE approach. Curr Pharm Design 2010; 16: 2676-709.
32. Garcia I, Fall Y, Gomez G. QSAR, docking, and CoMFA studies of GSK3 inhibitors. Curr Pharm Design 2010; 16: 2666-75.
33. Gonzalez-Diaz H. QSAR and complex networks in pharmaceutical design, microbiology, parasitology, toxicology, cancer, and neurosciences. Curr Pharm Design 2010; 16: 2598-600.
34. Gonzalez-Diaz H, Romaris F, Duardo-Sanchez A, et al. Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issues. Curr Pharm Design 2010; 16: 2737-64.
35. Marrero-Ponce Y, Casanola-Martin GM, Khan MT, Torrens F, Rescigno A, Abad C. Ligand-based computer-aided discovery of tyrosinase inhibitors. Applications of the TOMOCOMD-CARDD method to the elucidation of new compounds. Curr Pharm Design 2010; 16: 2601-24.
36. Munteanu CR, Fernandez-Blanco E, Seoane JA, et al. Drug discovery and design for complex diseases through QSAR computational methods. Curr Pharm Design 2010; 16: 2640-55.
37. Roy K, Ghosh G. Exploring QSARs with Extended Topochemical Atom (ETA) indices for modeling chemical and drug toxicity. Curr Pharm Design 2010; 16: 2625-39.
38. Speck-Planche A, Scotti MT, de Paulo-Emerenciano V. Current pharmaceutical design of antituberculosis drugs: future perspectives. Curr Pharm Design 2010; 16: 2656-65.
39. Vazquez-Naya JM, Martinez-Romero M, Porto-Pazos AB, et al. Ontologies of drug discovery and design for neurology, cardiology and oncology. Curr Pharm Design 2010; 16: 2724-36.
40. Bornholdt S, Schuster HG. Handbook of Graphs and Complex Networks: from the Genome to the Internet. Wheinheim: WILEYVCH GmbH CO. KGa 2003.
41. Breiger R. The analysis of social networks. In Handbook of Data Analysis, Hardy M, Bryman A, Eds. London: Sage Publications 2004; pp. 505-26.
42. th ed. London: Penguin 2000.
43. Craig C. Social structure. In: dictionary of the social sciences. Oxford: Oxford University Press 2002.
44. White H. Scott boorman and ronald breiger. social structure from multiple networks: I blockmodels of roles and positions. Am J Soc 1976; 81: 730-80.
45. Wellman B, Berkowitz SD. Social structures: a network approach. Cambridge: Cambridge University Press 1988.
46. Newman M. The structure and function of complex networks. SIAM Rev 2003; 56: 167-256.
47. Newman M. The structure and function of complex networks. SIAM Rev 2003; pp. 167-256.
48. Moreno JL. Who shall survive? New York: Beacon House 1934.
49. Padgett JF, Ansell CKJF. Robust action and the rise of the Medici, 1400-1434. Am J Soc 1993; 98: 259-1319.
50. Mariolis P. Interlocking directorates and control of corporations: The theory of bank control. Soc Sci Quart 1975; 56: 425-39.
51. Mizruchi MS. The American Corporate Network 1904-1974. Sage: Beverly Hills 1982.
52. Klovdahl AS, Potterat JJ, Woodhouse DE, Muth JB, Muth SQ, Darrow WW. Social networks and infectious disease: The colorado springs study. Soc Sci Med 1994; 38: 79-88.
53. Liljeros F, Edling CR, Amaral LAN, Stanley HE, Aberg Y. The webof human sexual contacts. Nature 2001; 411: 907-8.
54. Estrada E, Uriarte E. Recent advances on the role of topological indices in drug discovery research. Curr Med Chem 2001; 8: 1573-88.
55. Garcia-Domenech R, Galvez J, de Julian-Ortiz JV, Pogliani L. Some new trends in chemical graph theory. Chem Rev 2008; 108: 1127-69.
56. Todeschini R, Consonni V. Handbook of Molecular Descriptors. Wiley-VCH: 2002.
57. González-Díaz H, Vilar S, Santana L, Uriarte E. Medicinal chemistry and bioinformatics-current trends in drugs discovery with networks topological indices. Curr Top Med Chem 2007; 7: 1025-39.
58. Estrada E. Generalization of topological indices. Chem Phys Lett 2001; 336: 248-52.
59. Gonzalez-Diaz H, Cruz-Monteagudo M, Vina D, Santana L, Uriarte E, De Clercq E. QSAR for anti-RNA-virus activity, synthesis, and assay of anti-RSV carbonucleosides given a unified representation of spectral moments, quadratic, and topologic indices. Bioorg Med Chem Lett 2005; 15: 1651-7.
60. Devillers J, Balaban AT. Topological indices and related descriptors in QSAR and QSPR. The Netherlands: Gordon and Breach 1999.
61. Matamala AR, Estrada E. Simplex optimization of generalized topological index (GTI-Simplex): A unified approach to optimize QSPR models. J Phys Chem A 2005; 109: 9890-5.
62. Matamala AR, Estrada E. Generalised topological indices: Optimisation methodology and physico-chemical interpretation. Chem Phys Lett 2005; 410: 343-7.
63. González-Díaz H, Cruz-Monteagudo M, Vina D, Santana L, Uriarte E, De Clercq E. QSAR for anti-RNA-virus activity, synthesis, and assay of anti-RSV carbonucleosides given a unified representation of spectral moments, quadratic, and topologic indices. Bioorg Med Chem Lett 2005; 15: 1651-7.
64. Hill T, Lewicki P. STATISTICS Methods and Applications. A comprehensive reference for science, industry and data mining. Tulsa: StatSoft 2006.
65. Karelson M, Lobanov VS, Katritzky AR. Quantum-chemical descriptors in QSAR/QSPR studies. Chem Rev 1996; 96: 1027-44.
66. Katritzky AR, Kulshyn OV, Stoyanova-Slavova I, et al. Antimalarial activity: a QSAR modeling using CODESSA PRO software. Bioorg Med Chem 2006; 14: 2333-57.
67. Altermann E, Klaenhammer TR. PathwayVoyager: pathway mapping using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. BMC Genomics 2005; 6: 60.
68. Estrada E, Diaz GA, Delgado EJ. Predicting infinite dilution activity coefficients of organic compounds in water by quantumconnectivity descriptors. J Comput Aided Mol Des 2006; 20: 539-48.
69. Estrada E, Uriarte E. Quantitative structure--toxicity relationships using TOPS-MODE. 1. Nitrobenzene toxicity to Tetrahymena pyriformis. SAR QSAR Environ Res 2001; 12: 309-24.
70. McKusick VA. Mendelian inheritance in man and its online version, OMIM. Am J Human Genet 2007; 80: 588-604.
71. Jiao S, Bailey CP, Zhang S, Ladunga I. Probabilistic peak calling and controlling false discovery rate estimations in transcription factor binding site mapping from ChIP-seq. Methods Mol Biol 2010; 674: 161-77.
72. Hoffman BT, Kopajtic T, Katz JL, Newman AH. 2D QSAR modeling and preliminary database searching for dopamine transporter inhibitors using genetic algorithm variable selection of Molconn Z descriptors. J Med Chem 2000; 43: 4151-9.
73. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25-9.
74. Fjodorova N, Novich M, Vrachko M, et al. Directions in QSAR modeling for regulatory uses in OECD member countries, EU and in Russia. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2008; 26: 201-36.
75. Fjodorova N, Novich M, Vrachko M, et al. Regulatory assessment of chemicals within OECD member countries, EU and in Russia. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2008; 26: 40-88.
76. International Legal Protection for Software. http://www.softwareprotection. com/ (25/9/2007).
77. Jansen FK, Freytag G. Immune reactions to fractions of crystalline insulin. II. May peri-insulitis be produced by an antigen different from true Sanger insulin? Diabetologia 1973; 9: 191-6.
78. Richards TW, Peirce BO, Baxter GP. Charles Robert Sanger. Science 1912; 35: 532.
79. Worth AP, Van Leeuwen CJ, Hartung T. The prospects for using (Q)SARs in a changing political environment--high expectations and a key role for the European Commission's joint research centre. SAR QSAR Environ Res 2004; 15: 331-43.
80. Worth AP, Hartung T, Van Leeuwen CJ. The role of the European centre for the validation of alternative methods (ECVAM) in the validation of (Q)SARs. SAR QSAR Environ Res 2004; 15: 345-58.
81. Walker J, Jaworska J, Comber M, Schultz T, Dearden J. Guidelines for developing and using quantitative structure-activity relationships. Environ Toxicol Chem 2003; 22: 1653-65.
82. OECD. Report on the regulatory uses and applications in OECD Member Countries of (Quantitative) Structure-Activity Relationchip (Q)SAR) Models in the assessment of new and existing chemicals. Paris: OECD Environment Health and Safety Publications 2006.
83. Jaworska J, Comber M, Auer C, Van Leeuwen CJ. Summary of a workshop on regulatory acceptance of (Q)SARs for human health and environmental endpoints. Environ Health Perspect Mini Monogr 2003; 10: 1358-60.
84. Benfenati E. The specificity of the QSAR models for regulatory purposes: the example of the DEMETRA project. SAR QSAR Environ Res 2007; 18: 209-20.
85. Porcelli C, Boriani E, Roncaglioni A, Chana A, Benfenati E. Regulatory perspectives in the use and validation of QSAR. A case study: DEMETRA model for Daphnia toxicity. Environ Sci Technol 2008; 42: 491-6.
86. Porcelli C, Roncaglioni A, Chana A, Benfenati E. A comparison of DEMETRA individual QSARs with an index for evaluation of uncertainty. Chemosphere 2008; 71: 1845-52.
87. Cronin MT, Jaworska JS, Walker JD, Comber MH, Watts CD, Worth AP. Use of QSARs in international decision-making frameworks to predict health effects of chemical substances. Environ Health Perspect 2003; 111: 1391-401.
88. Edler L, Poirier K, Dourson M, et al. Mathematical modeling and quantitative methods. Food Chem Toxicol 2002; 40: 283-326.
89. Barratt R, Balls M. An overall strategy for the testing of chemicals for human hazard and risk assessment under the EU REACH system. Altern Lab Anim 2003; 31: 19-20.
90. Koeter HB, Visser R. Work in OECD on chemical safety: approaches for human risk assessment. Ind Health 2000; 38: 109-19.
91. Coecke S, Ahr H, Blaauboer BJ. Metabolism: a bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM Workshop 54. Altern Lab Anim 2006; 34: 49-84.
92. Benfenati E. The CAESAR project for in silico models for the REACH legislation. Chem Cent J 2010; 4 (Suppl 1): I1.
93. Steering committee for intellectual property issues in software computer science and telecommunications board commission on physical sciences M and applications national research council. Intellectual Property Issues In software. Washington, D. C: National Academy Press 1991.
94. Westkamp GN. Protección del material biológico mediante derechos de autor. Vuelta de la Bioinformática a los Derechos de autor en la biotecnología? IPR-Helpdesk Bulletin 2005.
95. Story A. Intellectual property and computer software. In intellectual property rights and sustainable development, ICTSDUNCTAD, Ed. Chavanod: Imprimerie Typhon 2004; p. 12.
96. Morcon C, Roughton A, Gaham J. The modern law of trade marks. London: Butterworth 2005.
97. WIPO. Madrid Agreement Concerning the International Registration of Marks of April 14, 1891, as revised at Brussels on December 14, 1900, at Washington on June 2, 1911, at The Hague on November 6, 1925, at London on June 2, 1934, at Nice on June 15, 1957, and at Stockholm on July 14, 1967,1 and as amended on September 28, 1979. http://www.wipo.int/madrid/en/legal_texts/-trtdocs_wo015.html
98. WIPO. Protocol Relating to the Madrid Agreement Concerning the International Registration of Marks adopted at Madrid on June 27, 1989 and amended on October 3, 2006. http://www.wipo.int/-madrid/en/legal_texts/trtdocs_wo016.html
99. Rowland D, Campbell A. Supply of software: copyright and contract Issues. Int J Law Inform Technol 2002; 10: 23-40(18).
100. Davidson SJ, Bergs SJ, Kapsner M. Open, click, download, send. what have you agreed to? The possibilities seem endless. Comp Assoc Law Conf (CLA 2001). 2001.
101. IPR-Helpdesk. Software Copyright Licensing. http://www.iprhelpdesk. org/docs/docs.EN/softwareCopyrightLicensing.html (2007).
102. OECD. Organization for Economic Co-operation and Development. Articles of the Model Convention Whit Respect to Taxes on Income and on Capital. http://www.oecd.org/dataoecd/50/49/3536-3840.pdf (15/9/2007).
103. Fowler JH, Jeon S. The authority of supreme court precedent. Soc Netw 2008; 30: 16-30.
104. Berca MN, Duardo-Sanchez A, González-Díaz H, Pazos A, Munteanu CR. Markov entropy for biology, parasitology, linguistic, technology, social and law networks. In: González-Díaz H, Prado-Prado FJ, García-Mera X, Eds. Complex network entropy: From Molecules to Biology, Parasitology, Technology, Social, Legal, and Neurosciences. Kerala, India: Transworld Res Network 2011; pp. 127-42.
105. Hem E, Bordahl PE. Max Sanger-father of the modern caesarean section. Gynecol Obstet Invest 2003; 55: 127-9.
106. Batagelj V, Mrvar A. Pajek 1.15. 2006.
107. Cruz-Monteagudo M, Munteanu CR, Borges F, et al. Stochastic molecular descriptors for polymers. 4. Study of complex mixtures with topological indices of mass spectra spiral and star networks: The blood proteome case. Polymer 2008; 49: 5575-87.
108. Bastian M, Hetmann S, Jacomy M. Gephi: An open source software for exploring and manipulating networks. International AAAI Conference on Weblogs and Social Media (ICWSM09), North America 2009.
109. Rudnick PA, Wang Y, Evans E, Lee CS, Balgley BM. Large scale analysis of MASCOT results using a Mass Accuracy-based THreshold (MATH) effectively improves data interpretation. J Proteome Res 2005; 4: 1353-60.
110. Yang CG, Granite SJ, Van Eyk JE, Winslow RL. MASCOT HTML and XML parser: an implementation of a novel object model for protein identification data. Proteomics 2006; 6: 5688-93.
111. Bouyssie D, Gonzalez de Peredo A, Mouton E, et al. Mascot file parsing and quantification (MFPaQ), a new software to parse, validate, and quantify proteomics data generated by ICAT and SILAC mass spectrometric analyses: application to the proteomics study of membrane proteins from primary human endothelial cells. Mol Cell Proteomics 2007; 6: 1621-37.
112. Moro S, Deflorian F, Bacilieri M, Spalluto G. Novel strategies for the design of new potent and selective human A3 receptor antagonists: an update. Curr Med Chem 2006; 13: 639-45.
113. Tokuda G, Lo N, Watanabe H, Arakawa G, Matsumoto T, Noda H. Major alteration of the expression site of endogenous cellulases in members of an apical termite lineage. Mol Ecol 2004; 13: 3219-28.
114. Devah P. Mark of a Criminal Record. Am J Soc 2003: 937-75.
115. Duardo-Sanchez A. Criminal law networks, markov chains, Shannon entropy and artificial neural networks. In: González-Díaz H, Prado-Prado FJ, García-Mera X, Eds. Complex Network Entropy: From Molecules to Biology, Parasitology, Technology, Social, Legal, and Neurosciences. Kerala, India: Transworld Res Network 2011; pp. 107-14.
116. Duardo-Sanchez A. Study of criminal law networks with Markovprobability centralities. In: González-Díaz H, Munteanu CR, Eds. Topological Indices for Medicinal Chemistry, Biology, Parasitology, Neurological and Social Networks, Kerala, India: Transworld Res Network 2010; pp. 205-12.
117. Junker BH, Koschuetzki D, Schreiber F. Exploration of biological network centralities with CentiBiN. BMC Bioinformatics 2006; 7: 219.
118. Estrada E, Rodriguez-Velazquez JA. Subgraph centrality in complex networks. Phys Rev E 2005; 71: 056103.
119. González-Díaz H, Prado-Prado F. Unified QSAR and networkbased computational chemistry approach to antimicrobials, Part 1: Multispecies activity models for antifungals. J Comput Chem 2008; 29: 656-7.
120. González-Díaz H, Sanchez IH, Uriarte E, Santana L. Symmetry considerations in Markovian chemicals 'in silico' design (MARCHINSIDE) I: central chirality codification, classification of ACE inhibitors and prediction of sigma-receptor antagonist activities. Comput Biol Chem 2003; 27: 217-27.
121. Estrada E, Molina E. 3D connectivity indices in QSPR/QSAR studies. J Chem Inf Comput Sci 2001; 41: 791-7.
122. Van Waterbeemd H. Chemometric methods in molecular design. New York: Wiley-VCH 1995.
123. Cruz-Monteagudo M, Gonzalez-Diaz H, Aguero-Chapin G, et al. Computational chemistry development of a unified free energy Markov model for the distribution of 1300 chemicals to 38 different environmental or biological systems. J Comput Chem 2007; 28: 1909-23.
124. Kutner MH, Nachtsheim CJ, Neter J, Li W. Standardized Multiple Regression Model. In Applied Linear Statistical Models, Fifth ed, New York: McGraw Hill 2005; pp. 271-7.